Volume 46, Issue 6 , Pages 687-700, June 2007
Weight Gain and Metabolic Effects of Mood Stabilizers and Antipsychotics in Pediatric Bipolar Disorder: A Systematic Review and Pooled Analysis of Short-Term Trials
To access this article, please choose from the options below
Supported by The Zucker Hillside Hospital NIMH Advanced Center for Intervention and Services Research for the Study of Schizophrenia MH 074543-01, and the NSLIJ Research Institute NIH General Clinical Research Center MO1RR018535. The author thanks Mani M. Pavuluri, M.D., for sharing unpublished results and Hanna M. Kester for her assistance with the manuscript.Disclosure: Dr. Correll serves as a consultant, advisor, and/or lecturer for AstraZeneca, Bristol-Myers Squibb, Otsuka, Eli Lilly, Intra-Cellular Therapeutics, Janssen, and Solvay.
PII: S0890-8567(09)62148-1
doi:10.1097/chi.0b013e318040b25f
© 2007 The American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
Volume 46, Issue 6 , Pages 687-700, June 2007
